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RESEARCH ARTICLE Open Access
Surgical experience and patient-related
restrictions predict the adequacy of cervical
mediastinoscopy in non-small cell lung
carcinoma lymph node staging
Theo J. Klinkenberg1, Wobbe Bouma1* , Caroline Van De Wauwer1, Rienhart F. E. Wolf1, Massimo A. Mariani1
and Harry J. M. Groen2
Abstract
Background: Until recently, cervical mediastinoscopy was considered to be the reference standard for mediastinal
staging for Non-Small Cell Lung Carcinoma (NSCLC). In the absence of metastases, mediastinal lymph node
involvement is the most important prognostic factor and as such it determines therapeutic strategies. In this
study we evaluated the adequacy of cervical mediastinoscopy in NSCLC lymph node staging in a large university hospital
over more than a decade. In addition, we determined the influence of: (1) surgeon’s experience (2) video-assisted
mediastinoscopy (VAM) and (3) patient-related restrictions (PRR) on the adequacy of lymph node sampling.
Methods: Between January 2001 and December 2014, 225 patients underwent cervical mediastinoscopy for lymph
node staging. Surgical and histological data were reviewed. Thirty-day follow-up was available for all patients. Lymph
node sampling was considered adequate when stations 4 L, 4R and 7 were sampled (ESTS guidelines). A surgeon was
considered to be experienced when he or she performed at least 40 procedures during the study-period.
Results: Intraoperative mortality was 0%. Thirty-day mortality was 1.3%. Overall adequacy of lymph node sampling was
56%. Univariate and multivariate logistic regression analyses of lymph node sampling adequacy revealed level of surgical
experience and PRR as independent predictors of lymph node sampling adequacy.
Conclusions: Surgical experience and PRR independently predict the adequacy of cervical mediastinoscopy in NSCLC
lymph node staging. VAM does not independently predict the adequacy of mediastinal lymph node sampling. In light of
the expected further decline in mediastinoscopy numbers, we recommend to limit this procedure exclusively to the
armamentarium of the experienced thoracic surgeon.
Keywords: Mediastinoscopy, Video-assisted mediastinoscopy, Non-small cell lung cancer, Experience
Background
Lung cancer is the leading cause of cancer death in de-
veloped countries and accounts for an estimated 20% of
all cancer deaths [1]. Five-year survival can be achieved
in 40–50% of patients with early stage non-small cell
lung carcinoma (NSCLC) [2]. Accurate staging based
on tumour size, regional lymph node involvement and
presence of metastasis is essential for treatment of NSCLC
patients [3–5]. In the absence of metastases, mediastinal
lymph node involvement is the most important prognostic
factor and determines therapeutic strategies; i.e. patients
with mediastinal nodal disease will in general not benefit
from upfront surgery [6, 7].
FluoroDeoxyGlucose - Positron Emission Tomography –
Computed Tomography (FDG-PET-CT), Endoscopic
UltraSound guided-Fine Needle Aspiration and EndoBron-
chial UltraSound guided-TransBronchial Needle Aspiration
(EUS-FNA/EBUS-TBNA) have become the most important
techniques in mediastinal lymph node assessment in recent
years [8, 9]. Cervical mediastinoscopy was considered to be
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the reference standard for mediastinal staging of lung
cancer. After its introduction in 1957 mediastinoscopy
has evolved considerably [10]. Video-assisted mediasti-
noscopy (VAM) was first reported in literature in 2002
[11] and was introduced at our center in September 2008
and from then on used in each mediastinoscopy case. VAM
improved visualization and facilitated teaching tremendously
[12]. However, no difference in sensitivity or negative pre-
dictive value was found when compared to conventional
mediastinoscopy [13]. Nevertheless, the revised ESTS guide-
lines recommend VAM over conventional mediastinoscopy
because of its superior visualization and safety [8].
Mediastinoscopy provides access to the upper paratra-
cheal lymph nodes (stations 2R and 2 L), the lower paratra-
cheal lymph nodes (stations 4R and 4 L) and subcarinal
lymph nodes (station 7) [8, 14, 15]. The European Society
of Thoracic Surgeons (ESTS) guidelines recommend to ac-
quire at least samples from the lower paratracheal lymph
nodes (stations 4R and 4 L) and the subcarinal lymph nodes
(station 7) [8]. If present, the upper paratracheal lymph
nodes should also be biopsied [8].
A well-executed cervical mediastinoscopy has a sensitivity
of 76–85% and a negative predictive value of 82–92% [16]
with an overall morbidity of 1.07% and mortality of 0.05%
[17]. It is however important to realize that these values are
largely dependent on the level of experience of the surgeon
and the extensiveness of lymph node sampling [18]. There-
fore, in daily practice, the actual adequacy and reliability of
cervical mediastinoscopy is expected to be lower.
In this study we evaluated the adequacy of mediastinal
lymph node sampling at our center over more than a
decade. In addition, we analyzed the influence of: (1)
surgeon’s experience, (2) the use of VAM and (3) patient-
related restrictions (PRR) on the adequacy of lymph node
sampling (based on the ESTS guidelines).
Methods
This study was conducted in accordance with the guide-
lines of the University Medical Center Groningen Insti-
tutional Review Board.
Patients
Between January 2001 and December 2014, 225 patients
underwent cervical mediastinoscopy for NSCLC lymph
node staging. VAM was introduced at our center in
September 2008 and from then on used in each mediasti-
noscopy case. Patient characteristics are summarized in
Table 1. Surgical and histological reports were reviewed.
Thirty-day follow-up of survivors was complete and no
patient was lost to follow-up.
Adequacy of lymph node sampling
Based on the ESTS guidelines the minimal require-
ment for adequate lymph node sampling during cervical
mediastinoscopy was defined as histologically proven sam-
ples from at least the left and right lower paratracheal
lymph nodes (station 4 L and 4R) and the subcarinal
lymph nodes (station 7) [8].
Level of surgical experience
The level of surgical experience was based on the num-
ber of cervical mediastinoscopies performed by individ-
ual surgeons. For surgeons who performed at least 40
Table 1 Preoperative Patient Data (n = 225)
Variablea Value




Histology primary lung tumor
Squamous cell carcinoma 118 (52)
Adenocarcinoma 59 (26)
Large cell carcinoma 45 (20)
Adenosquamous carcinoma 2 (1)















Purpose of cervical mediastinoscopy
Staging 138 (61)
Staging of tumor with unknown histology 66 (29)
Restaging after chemotherapy 20 (9)
Restaging after earlier mediastinoscopy 1 (0)
Video cervical mediastinoscopy 187 (83)
Level of surgeon’s experience
Experienced surgeon 129 (57)
Less experienced surgeon 96 (43)
aData are presented as mean ± standard deviation or number (%)
bBased on the 8th edition of the TNM classification for lung cancer
(International Association for the Study of Lung Cancer)
NSCLC non-small cell lung carcinoma
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mediastinoscopies during the study-period the adequacy
of lymph node sampling was > 70%. Therefore experi-
enced surgeons were defined as those who performed at
least 40 mediastinoscopies during the study-period. Based
on these criteria two out of sixteen surgeons could be con-
sidered experienced. Both experienced surgeons in this
study were trained as thoracic surgeons.
Patient-related restrictions (PRR)
PRR were defined as intraoperative conditions or findings,
which complicated the adequacy of lymph node sampling.
An overview of PRR is shown in Table 2.
Follow-up
Follow-up was obtained directly from outpatient visits
or by telephone interview with the patient and/or the re-
ferring physician. Thirty-day follow-up was complete.
Statistics
Continuous variables were expressed as mean ± SD. Cat-
egorical variables were expressed as percentages. Compar-
isons between groups were performed using Pearson’s X2
test or Fisher’s exact test as appropriate for categorical
variables and the independent samples t-test or Mann-
Whitney U test, as appropriate for continuous variables.
Univariate variables with P < 0.10 were included in the
multivariate analysis. Age and gender were forced in the
multivariate model. Multivariate logistic regression ana-
lyses by means of a forward stepwise algorithm were per-
formed to identify independent predictors of lymph node
sampling adequacy. Odds ratios were reported with 95%
confidence intervals (CI). Goodness-of-fit of the final lo-
gistic regression models was assessed with the Hosmer-
Lemeshow statistic.
All calculations were performed using a commercially
available statistical package (IBM SPSS Statistics 22.0;
IBM Corporation, Armonk, NY). Statistically significant
differences were defined as P < 0.05.
Results
Lymph node sampling adequacy and its predictors based
on the ESTS guidelines
The overall adequacy of lymph node sampling was 56%.
In patients who underwent cervical mediastinoscopy by
an experienced surgeon, adequacy of lymph node sampling
was 64%, versus 47% when operated by a less experienced
surgeon (P = 0.013, Table 3). When PRR occurred, ad-
equacy of lymph node sampling was 20%, versus 60%
when these restrictions did not occur (P = 0.002, Table 3).
The distribution of PRR was not different between patients
operated by experienced or less experienced surgeons. PRR
did not differ significantly between less experienced
and experienced surgeons (PRR 7.8% vs. 10.4%, respect-
ively and P = 0.489). Univariate and multivariate logistic
regression analyses of lymph node sampling adequacy
are shown in Table 3. Multivariate analysis revealed level of
surgeon’s experience and PRR as independent predictors of
lymph node sampling adequacy. The Hosmer-Lemeshow
goodness-of-fit test was non-significant, indicating that this
multivariate model is a good fit (X2 = 0.24, df = 1, P =
0.878).
Thirty-day mortality and post-operative complications
An overview of thirty-day mortality and post-operative
complications is provided in Table 2. Thirty-day mortality
was 1.3% (n = 3). All deaths were unrelated to cervical me-
diastinoscopy. Causes of death included cerebrovascular
accident and respiratory insufficiency after partial man-
dibular resection for a second primary tumour, respiratory
insufficiency after thoracotomy and rib resection, and
multi-organ failure after early bronchial fistula formation
following right-sided pneumonectomy.
Discussion
This study demonstrates that surgical experience as well
as PRR are independent and powerful predictors of the
Table 2 Intraoperative and Postoperative Patient Data (n = 225)
Variablea Value
Mean number of sampled lymph node stations (per patient) 3.5 ± 1.2
Mean number of samples taken (per patient) 11.0 ± 7.3
Adequate lymph node sampling
Based on the ESTS guidelines 127 (56)
Patient-related restrictions 20 (8.9)
Adhesions 7 (3.1)
Bleeding, imparing sight 4 (1.8)
Tumor growth into the mediastinum (inablity to reach
all stations)
2 (0.9)
Adequate biopsy of very suspicious node (no further
biopsies taken)
2 (0.9)
Patient habitus 1 (0.4)
Extremely limited neck mobility 1 (0.4)
No samples taken on left side due to pre-op hoarseness 1 (0.4)
Struma 1 (0.4)
Anomaly of the innominate vein 1 (0.4)
Intraoperative mortality 0 (0)
Thirty-day mortality 3 (1.3)
Post-operative complications 7 (3.1)
Permanent recurrent laryngeal nerve lesion 3 (1.3)
Bleeding (causing respiratory insufficiency and intubation) 1 (0.4)
Pneumonia 1 (0.4)
Pneumothorax treated with chest tube 1 (0.4)
Atrial fibrillation 1 (0.4)
aData are presented as mean ± standard deviation or number (%)
ESTS European Society of Thoracic Surgeons
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adequacy of cervical mediastinoscopy in NSCLC lymph
node staging. When an experienced surgeons performs
the mediastinoscopy adequate lymph node sampling is
almost 2 times more likely than when a less experienced
surgeon performs the mediastinoscopy (OR 1.96) and
when PRR are not present adequate lymph node sampling
is almost 6 times more likely than when PRR are present
(OR 5.94). Other studies have also shown that mediasti-
noscopy yield depends strongly on operator skills [18, 19]
and lymph node location [20]. The most frequent PRR in
this study included adhesions, bleeding (impairing sight),
and tumor growth into the mediastinum (inability to
reach all lymph node stations). Although PRR did not dif-
fer significantly between less experienced and experienced
surgeons, one might assume that a more experienced sur-
geon might be able to overcome certain PRR more easily
than a less experienced surgeon. However, our data do not
support this assumption. Both surgical experience and
PRR proved to be independent predictors in multivariate
analysis.
One of the drawbacks of conventional mediastinoscopy is
the uncomfortable position for the surgeon. The surgeon
has only a narrow view through the instrument and has to
find a way among anatomical entities such as; trachea,
esophagus, azygos vein, right pulmonary artery, recurrent
nerve and pleural space/lung, and depending on patient
anatomy; the carotid and innominate arteries. As such,
conventional mediastinoscopy is a complex procedure and
teaching can also be difficult because of the risk of ‘collat-
eral damage’. These events strongly depend on the experi-
ence and teaching skills of the surgeon. VAM, with its
superior visualization and teaching possibilities, has made
the procedure safer and easier to adopt for surgeons in
training [21]. In this study the use of VAM was not an inde-
pendent predictor of adequacy of lymph node sampling,
which supports the general observation that the superior
visualization with VAM does not lead to a higher quality of
mediastinal lymph node sampling compared to conven-
tional mediastinoscopy [13].
Successful treatment of patients with NSCLC strongly
depends on strict and reliable staging. The mediastinal
lymph node status determines the sequence of treatment
modalities. Until recently, mediastinoscopy was the gold
standard for invasive mediastinal lymph node staging in
NSCLC. Mediastinoscopy provides access to upper paratra-
cheal lymph nodes (stations 2R and 2 L), lower paratracheal
lymph nodes (stations 4R and 4 L) and subcarinal lymph
nodes (station 7) [14], and has limitations in assessing the
posterior subcarinal, lower mediastinal, and hilar lymph
nodes [22]. EBUS-TBNA and EUS-FNA have shown to be
at least equivalent to mediastinoscopy in sensitivity and
negative predictive value [16]. For that reason, and because
of the minimally invasive character of these procedures,
they are currently recommended to be first choice for
invasive mediastinal lymph node staging in lung cancer
[8]. EBUS-TBNA and EUS-FNA are safe procedures
with minor complications, reported in less than 1% of
cases [23, 24]. Especially the combination of EBUS-TBNA
and EUS-FNA allows complete access to nearly all lymph
nodes of the mediastinum [25, 26]. However, pathological
assessment of the yield of both procedures is only possible
by cytology instead of histology. The samples obtained by
needle aspiration are non-diagnostic in a significant num-
ber of cases [27] and depend strongly on operator skills
[22]. These non-diagnostic cases led to the development
of Rapid On-Site Evaluation of the aspirate in order to
increase accuracy. This is achieved by monitoring on-site
microscopy of repeated lymph node aspirations in differ-
ent directions of the node until representative samples
have been obtained [28].
Limitations of our study include the long time frame
and the retrospective design.
Both mediastinoscopy and endosonography are complex
technical procedures and depend strongly on operator
skills and experience. The complexity of a procedure is in-
versely related to the adoptability of a procedure [29].
Complexity and adoptability determine the steepness of
the learning curve of a procedure and depends on the
quantity of procedures performed by the operator. With
the growing experience in endosonography, the quantity
of mediastinoscopies performed for mediastinal staging in
NSCLC is likely to fall back and with it, the adoptability.
In this study, we have shown that surgical experience and
PRR are key in adequate lymph node sampling. Therefore,
Table 3 Predictors of lymph node sampling adequacy by univariate analysis and multivariate logistic regression
Variable Univariate analysis Multivariate analysis
OR 95% CI P value OR 95% CI P value
Age, years 1.02 0.99–1.05 0.141 – – –
Female sex 1.51 0.81–2.79 0.192 – – –
Squamous cell carcinoma histology 1.14 0.96–1.36 0.147 – – –
Video cervical mediastinoscopy 0.40 0.19–0.87 0.021 – – –
Experienced surgeon 1.98 1.16–3.39 0.013 1.96 1.13–3.41 0.017
No patient related restrictions 6.00 1.94–18.59 0.002 5.94 1.90–18.60 0.002
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in light of the expected further decline in mediastinoscopy
numbers, we recommend to limit this procedure exclu-
sively to the armamentarium of the experienced thoracic
surgeon.
Conclusions
Surgical experience and PRR are powerful and independent
predictors of the adequacy of cervical mediastinoscopy in
NSCLC lymph node staging. Experience and skills vary
with the training of the operator. Therefore, a solid training
is required in educational programs and every center has to
look at its own diagnostic yield and negative predictive
value. VAM with its superior visualization and teaching
possibilities, makes the procedure safer and easier to adopt
for surgeons in training, but does not independently predict
the adequacy of lymph node sampling. Since mediastinal
lymph node staging is crucial in patient treatment and out-
come, we urge that cervical mediastinoscopy should be per-
formed and taught by experienced thoracic surgeons only.
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